Clinical trials
Completed Phase 1 Cardiomyopathy, Hypertrophic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shandong Suncadia Medicine Co., Ltd. | 3 |
| Bristol-Myers Squibb | 2 |
| MyoKardia, Inc. | 2 |
| Atridia Pty Ltd. | 1 |
| Corxel Pharmaceuticals | 1 |
| Cytokinetics | 1 |
| LianBio LLC | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Rocket Pharmaceuticals Inc. | 1 |
| The University of Texas Health Science Center, Houston | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 14 |
| Cardiovascular Diseases | 1 |
| Glycogen Storage Disease Type IIb | 1 |
| Heart Diseases | 1 |
| Hypertrophy | 1 |
| Ventricular Outflow Obstruction, Left | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.